CAS 1456891-34-1

Fórmula: C24H36N8O

InChI: InChI=1S/C24H36N8O/c1-4-25-13-14-32(5-2)24-30-22(27-17(3)18-9-7-6-8-10-18)29-23(31-24)28-19-11-12-20-21(15-19)33-16-26-20/h11-12,15-18,25H,4-10,13-14H2,1-3H3,(H2,27,28,29,30,31)/t17-/m0/s1

Chave InChI: DEDHMXBDEJSZFE-KRWDZBQOSA-N

SMILES: CCNCCN(CC)C1=NC(=NC(=N1)N[C@@H](C)C2CCCCC2)NC3=CC4=C(C=C3)N=CO4

(S)-N2-(Benzo[D]Oxazol-6-Yl)-N4-(1-Cyclohexylethyl)-N6-Ethyl-N6-(2-(Ethylamino)Ethyl)-1,3,5-Triazine-2,4,6-Triamine

CAS: 1456891-34-1

(S)-N2-(Benzo[D]Oxazol-6-Yl)-N4-(1-Cyclohexylethyl)-N6-Ethyl-N6-(2-(Ethylamino)Ethyl)-1,3,5-Triazine-2,4,6-Triamine

Fórmula: C₂₄H₃₆N₈O

Pureza: 98%

Peso molecular: 452.6

Ref: 54-OR1023048

LS-102

CAS: 1456891-34-1

LS-102: E3 ligase inhibitor, IC50 35 μM, potential RA therapy.

Fórmula: C₂₄H₃₆N₈O

Pureza: 98.92%

Cor e Forma: Solid

Peso molecular: 452.5956

Ref: TM-T11879

(S)-N2-(Benzo[d]oxazol-6-yl)-N4-(1-cyclohexylethyl)-N6-ethyl-N6-(2-(ethylamino)ethyl)-1,3,5-triazine-2,4,6-triamine

CAS: 1456891-34-1

Fórmula: C₂₄H₃₆N₈O

Pureza: 98%

Peso molecular: 452.5956

Ref: IN-DA024H1V

LS-102

CAS: 1456891-34-1

(S)-N2-(Benzo[d]oxazol-6-yl)-N4-(1-cyclohexylethyl)-N6-ethyl-N6-(2-(ethylamino)ethyl)-1,3,5-triazine-2,4,6-triamine

Fórmula: C₂₄H₃₆N₈O

Pureza: 98%

Peso molecular: 452.6

Ref: IN-DG01270626

(S)-N2-(Benzo[d]oxazol-6-yl)-N4-(1-cyclohexylethyl)-N6-ethyl-N6-(2-(ethylamino)ethyl)-1,3,5-triazine-2,4,6-triamine

CAS: 1456891-34-1

Fórmula: C₂₄H₃₆N₈O

Pureza: 98%

Peso molecular: 452.607

Ref: 10-F549426

(S)-N2-(Benzo[D]oxazol-6-yl)-N4-(1-cyclohexylethyl)-N6-ethyl-N6-(2-(ethylamino)ethyl)-1,3,5-triazine-2,4,6-triamine

CAS: 1456891-34-1

Please enquire for more information about (S)-N2-(Benzo[D]oxazol-6-yl)-N4-(1-cyclohexylethyl)-N6-ethyl-N6-(2-(ethylamino)ethyl)-1,3,5-triazine-2,4,6-triamine including the price, delivery time and more detailed product information at the technical inquiry form on this page

Fórmula: C₂₄H₃₆N₈O

Pureza: Min. 95%

Peso molecular: 452.6 g/mol

Ref: 3D-GIC89134